Cargando…
2548. Pharmacokinetic Analysis of Co-Administering Doravirine, Tenofovir Disoproxil Fumarate, Estradiol, and Spironolactone
BACKGROUND: Despite the availability of doravirine (DOR) as a fixed-dose combination product and its favorable safety profile, transgender women (TGW) are less likely to adhere to antiretroviral therapy over concerns of drug interactions with feminizing hormone therapy. This study evaluated the effe...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678228/ http://dx.doi.org/10.1093/ofid/ofad500.2165 |